GHO Capital and Partners Group completed the investment in Sterling Pharma.

GHO Capital, a healthcare investment company, and Partners Group, a global private markets firm, completed the investment in Sterling Pharma, a global contract development and manufacturing organisation. Financial terms were not disclosed. “We have achieved remarkable growth over the last four years becoming a trusted partner to the pharmaceutical and biotechnology industries. We are proud of our success in meeting the often complex and demanding manufacturing needs of our customers on an international scale. Our continued sustainable growth has been underpinned by our partnership with GHO Capital, which has been instrumental in our success to date. We are delighted to welcome Partners Group, which, alongside GHO, will support our ambitious global growth trajectory. We look forward to continuing to provide industry leading service throughout the entire product lifecycle, to an ever-expanding international customer base,” Kevin Cook, Sterling Pharma CEO.